The Latest Breaking News from Medicare

Democrats have long wanted to allow Medicare to negotiate drug prices, which it hopes will lead to lower prescription costs

Government claims prices could fall for 9m seniors but pharma companies claim cost-reduction program is unconstitutional

The program is a major priority for Joe Biden, who ran for president in part on the promise to allow Medicare to negotiate drug prices.

The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026. In the meantime, drugmakers are fighting the negotiations with lawsuits.

One of the biggest expenses Medicare beneficiaries are likely to face will be long-term care.

Since the start of the COVID pandemic, there has been more attention given to problems of mental ill-health including depression than ever before. A new therapeutic option, especially for depression, transcranial magnetic stimulation, is slowly helping to address some of these considerable unmet needs in our community.

A stair lift can cost thousands of dollars and is not covered by traditional Medicare.

One in every four senior Americans with dementia or mild cognitive impairment lives alone, making them vulnerable to risky driving, wandering outside the home, mixing up medications, and skipping appointments. Read further on Dynamite News:

Thanks to the non-cyclical nature and the increasing demand for healthcare services, the healthcare industry should continue to brave most market challenges. Hence, it could be an opportune time to explore dominating medical stocks: Elevance Health (ELV), Centene Corp. (CNC), and Molina Healthcare (MOH), which might garner substantial returns for…